Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

  • There is currently no data for JADE

Expanded Investment Focus

22 Jul 2021 07:00

RNS Number : 0364G
Jade Road Investments Limited
22 July 2021
 

22 July 2021

RNS

JADE ROAD INVESTMENTS LIMITED

("Jade Road" or the "Company")

Expanded Investment Focus

 

Jade Road Investments Limited, the London-quoted, pan-Asian diversified investment vehicle focused on providing shareholders with attractive uncorrelated, risk-adjusted long-term returns, is pleased to announce that the Company's investment focus will expand to look to invest in Asian High Growth Companies via equity (in listed companies and/or pre-IPO investments) as part of its existing investment policy. While Jade Road will consider opportunities in all sectors as they arise, potential opportunities in Technology, including Health-Tech, Med-Tech and Fin-Tech will be prioritised.

The Total Allocation under this expanded investment focus will be no more than 10% of Jade Road's present NAV (as of 31 December 2020: USD106.4m) and no more than 20% once the NAV exceeds USD150m. Investments in each company will not exceed 5% of the Total Allocation, in order to mitigate risk through diversification. Potential investments will be sourced through brokers and financial institutions as well as through various networks established on the ground in Asia by the Company's Directors and its investment manager, Harmony Capital.

The relatively small portion of capital allocated to equity presents reasonable upside opportunities, while simultaneously protecting the Company against possible risk through a granular sub-portfolio, whose overall NAV attribution would be less than 20% at the very maximum.

Acquiring equity in high growth companies presents Jade Road with the opportunity to accelerate the growth of its NAV through capital gains in successful investments. The Company believes that investing in the equity of pre-IPO companies also increases the feasibility of an exit strategy from an eventual listing on the public markets. 

Jade Road invests in visionary entrepreneurs developing innovative companies that solve problems in their industries. The Company is dedicated to the success of each of its portfolio companies and believes that their products and/or their services can be transformative on a local and global scale.

Jade Road is principally focused on early-stage investments. The company aims to bring investment opportunities often reserved for the private market of venture capital firms to the public market via its own shares being publicly traded.

John Croft, chairman of Jade Road Investments Ltd commented: "With many high growth start-ups staying private longer, access to these companies has been out of reach for the average investor. Jade Road is uniquely poised to eliminate the barriers to investing in these start-ups and provide investors with access to these opportunities of potential high returns."

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Jade Road Investment Limited

+44 (0) 778 531 5588

John Croft

Lionsgate Communications - Communications Adviser

+44 (0) 779 189 2509

Jonathan Charles

Hybridan LLP - Corporate Broker

+44 (0)203 764 2341

Claire Noyce

WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce

James Sinclair Ford

 

 

About Jade Road Investments Limited

Jade Road Investments Limited (Jade Road) is quoted on the AIM Market of the London Stock Exchange and is committed to providing shareholders with attractive uncorrelated, risk adjusted long-term returns from a combination of realising sustainable capital growth and delivering dividend income.

 

The Company is focused on providing growth capital and financing to emerging and established Small and Medium Enterprises (SME) sector throughout Asia, well diversified by national geographies, instruments and asset classes. This vital segment of the economy is underserved by the traditional banking industry for regulatory and structural reasons.

 

The Company's investment manager, Harmony Capital, seeks to capitalise on its team's established investment expertise and broad networks across Asia. Through rigorous diligence and disciplined risk management, Harmony Capital is dedicated to delivering attractive income and capital growth for shareholders with significant downside protection through selectively investing in assets and proactively managing them.

 

Harmony Capital is predominately sourcing private opportunities and continues to create a strong pipeline of attractive income generating assets from potential investments in growth sectors across Asia, including healthcare, fintech, hospitality, IT and property. 

 

For further information, please visit the Company's website at https://jaderoadinvestments.com and follow the Company on Twitter (@JadeRoadInvest).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEFLFLFDLLBBF
Date   Source Headline
8th Jun 202611:31 amRNSVoting Results
22nd May 20262:50 pmRNSNew Investing Policy & Share Combination Circular
28th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSAppointments & Resignations of Non-exec Directors
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
11th Feb 20262:27 pmRNSCancellation of CLN subscription agreement
9th Feb 202611:00 amRNSRestoration - Jade Road Investments Limited
9th Feb 202611:00 amRNSEquity Subscription and Restoration of Trading
30th Jan 20267:00 amRNSEquity Subscription and Related Party Transaction
21st Jan 20265:57 pmRNSRe-denomination of trading currency
8th Jan 202612:06 pmRNSVoting Results
23rd Dec 20254:20 pmRNSConversion Notice
23rd Dec 20254:20 pmRNSConversion Notice
23rd Dec 20257:30 amRNSShare Combination Circular
23rd Dec 20257:30 amRNSShare Combination Circular
1st Dec 20257:00 amRNSProposed Fundraising and Suspension Update
17th Nov 20255:38 pmRNSAppointment of Nicolas Vassaux
3rd Nov 20255:28 pmRNSProposed Appointment of New Director
28th Oct 20252:09 pmRNSVoting Results
10th Oct 20257:00 amRNSWaiver of Takeover Provision, New Investing Policy
24th Sep 20254:46 pmRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2025
16th Sep 202512:15 pmRNSChange of Advisor
11th Sep 20251:05 pmRNSEquity Fundraising
3rd Jul 20251:09 pmRNSAnnual Financial Report
30th Jun 20255:57 pmRNSAnnual Results for 2024
29th May 20257:30 amRNSSuspension - Jade Road Investments Limited
29th May 20257:00 amRNSTemporary suspension of trading on AIM
27th May 20254:01 pmRNSSubscription Agreement
6th May 20253:00 pmRNSSubscription Update
28th Apr 20257:00 amRNSSubscription Agreement
11th Apr 202512:50 pmRNS2024 AGM Voting Results
1st Apr 20254:00 pmRNSTermination of investment with Woollard & Hall Ltd
20th Mar 20257:00 amRNSNotice of AGM, New Investing Policy & Share Reorg.
13th Mar 20257:45 amRNSTermination of Heirloom as Investment Manager
24th Feb 20257:00 amRNSProposed Change to Investing Policy
7th Feb 202512:45 pmRNSInvestment Commitment, Equity Fundraising and CLN
20th Nov 20243:11 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
25th Sep 20247:00 amRNSFurther tranche of convertible loan notes
18th Sep 20248:21 amRNSUpdate on strategic partnership with MBM Limited
16th Aug 20243:10 pmRNSStrategic partnership with MBM Limited
15th Jul 20247:00 amRNSChange of Nominated Adviser
11th Jul 20247:00 amRNSResignation of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.